What 4 Analyst Ratings Have To Say About Cullinan Oncology
What 4 Analyst Ratings Have To Say About Cullinan Oncology
Analysts have provided the following ratings for Cullinan Oncology (NASDAQ:CGEM) within the last quarter:
分析师在上个季度对库利南肿瘤学(纳斯达克：CGEM)提供了以下评级：
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 1 | 0 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 1 | 0 | 0 | 0 | 0 |
| 2M Ago | 1 | 1 | 0 | 0 | 0 |
| 3M Ago | 0 | 0 | 0 | 0 | 0 |
| 看涨 | 有点看涨 | 漠不关心 | 有点悲观 | 看跌 | |
|---|---|---|---|---|---|
| 总评等 | 3. | 1 | 0 | 0 | 0 |
| 最近30天 | 1 | 0 | 0 | 0 | 0 |
| 1个月前 | 1 | 0 | 0 | 0 | 0 |
| 两个月前 | 1 | 1 | 0 | 0 | 0 |
| 3个月前 | 0 | 0 | 0 | 0 | 0 |
These 4 analysts have an average price target of $42.25 versus the current price of Cullinan Oncology at $10.58, implying upside.
这4位分析师的平均目标价为42.25美元，而库利南肿瘤学的当前价格为10.58美元，这意味着上涨。
Below is a summary of how these 4 analysts rated Cullinan Oncology over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the more negative analysts are on the stock
以下是过去3个月这4位分析师对库利南肿瘤学的评级摘要。看涨评级的数量越多，分析师对股票的正面评价就越多，看跌评级的数量越多，分析师对股票的负面评价就越多
This current average has increased by 56.48% from the previous average price target of $27.00.
目前的平均价格比之前的平均价格目标27.00美元上涨了56.48%。
Stay up to date on Cullinan Oncology analyst ratings.
请随时了解库利南肿瘤分析师的最新评级。
If you are interested in following small-cap stock news and performance you can start by tracking it here.
如果你对关注小盘股的新闻和表现感兴趣，你可以从这里开始追踪它。
What Are Analyst Ratings?
什么是分析师评级？
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
分析师在银行和金融系统工作，通常专门报告股票或定义的行业。分析师可能会参加公司的电话会议和会议，研究公司的财务报表，并与内部人士交流，发布对股票的“分析师评级”。分析师通常每季度对每只股票进行一次评级。
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
一些分析师还将提供对增长预期、收益和收入等指标的预测，以提供对股市的进一步指导。使用分析师评级的投资者应该注意到，这种专门的建议来自人类，可能会出错。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成，并由编辑审阅。